Changes in the Oxidation-Reduction State of Human Dermal Fibroblasts as an Effect of Lomefloxacin Phototoxic Action.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
19 06 2022
Historique:
received: 14 04 2022
revised: 28 05 2022
accepted: 17 06 2022
entrez: 24 6 2022
pubmed: 25 6 2022
medline: 28 6 2022
Statut: epublish

Résumé

Phototoxicity induced by antibiotics is a real problem in health care. The discontinuation of antibiotic therapy due to a phototoxic reaction can lead to the development of resistant strains. Fluoroquinolones are widely used antibiotics that exhibit phototoxic activity under UVA radiation. The purpose of the study was to examine the redox status of human dermal fibroblasts exposed to UVA radiation and treated with lomefloxacin, the most phototoxic fluoroquinolone. Lomefloxacin alone was found to have an antiproliferative activity on fibroblasts by affecting the cell cycle. In addition, the drug caused a redox imbalance associated with the decreased expression of catalase and glutathione peroxidase. UVA radiation increased the drug cytotoxicity and oxidative stress induced by lomefloxacin. The decrease in cell viability was accompanied by a high level of reactive oxygen species and extensive changes in the antioxidant levels. The revealed data indicate that the phototoxic action of lomefloxacin results from both increased reactive oxygen species production and an impaired antioxidant defense system. Considering all of the findings, it can be concluded that lomefloxacin-induced phototoxic reactions are caused by an oxidoreductive imbalance in skin cells.

Identifiants

pubmed: 35741100
pii: cells11121971
doi: 10.3390/cells11121971
pmc: PMC9222184
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Anti-Infective Agents 0
Antioxidants 0
Fluoroquinolones 0
Quinolones 0
Reactive Oxygen Species 0
lomefloxacin L6BR2WJD8V

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Photochem Photobiol. 2004 Mar;79(3):248-58
pubmed: 15115297
Exp Neurobiol. 2015 Dec;24(4):325-40
pubmed: 26713080
Immunology. 2020 Jun;160(2):116-125
pubmed: 31709535
Antioxid Redox Signal. 2002 Aug;4(4):665-73
pubmed: 12230879
Toxicol In Vitro. 2019 Mar;55:75-92
pubmed: 30528372
Cells. 2019 Jun 18;8(6):
pubmed: 31216669
Pharmaceuticals (Basel). 2021 Jul 26;14(8):
pubmed: 34451820
Pharmacol Rep. 2015 Feb;67(1):38-43
pubmed: 25560573
Int J Mol Sci. 2020 Dec 19;21(24):
pubmed: 33352719
JBRA Assist Reprod. 2018 Mar 01;22(1):61-66
pubmed: 29266896
Cells. 2021 Oct 27;10(11):
pubmed: 34831123
Pharmacol Rep. 2013;65(3):689-99
pubmed: 23950592
Clin Infect Dis. 1999 Feb;28(2):352-64
pubmed: 10064255
J Clin Invest. 1984 Oct;74(4):1398-403
pubmed: 6541229
Clin Biochem. 1999 Nov;32(8):595-603
pubmed: 10638941
Physiol Rev. 2004 Oct;84(4):1155-228
pubmed: 15383650
J Dermatol Sci. 1999 Sep;21(1):27-33
pubmed: 10468189
Redox Biol. 2015 Dec;6:183-197
pubmed: 26233704
Drug Saf. 2020 Jun;43(6):561-566
pubmed: 32146702
J Invest Dermatol. 2003 Sep;121(3):596-606
pubmed: 12925221
Postepy Hig Med Dosw (Online). 2008 Mar 26;62:118-24
pubmed: 18388851
Int J Mol Sci. 2013 Jun 07;14(6):12222-48
pubmed: 23749111
J Invest Dermatol. 2006 Dec;126(12):2565-75
pubmed: 17108903
Br J Cancer. 2002 Feb 1;86(3):443-8
pubmed: 11875713
Drug Chem Toxicol. 2006 Jan;29(1):25-38
pubmed: 16455588
Cutan Ocul Toxicol. 2017 Jun;36(2):169-175
pubmed: 27572617
Clin Cornerstone. 2003;Suppl 3:S29-36
pubmed: 14992418
Eur J Pharmacol. 2010 Jan 25;626(2-3):146-53
pubmed: 19818344
J Infect Chemother. 2020 Jun;26(6):535-539
pubmed: 32081646
Photochem Photobiol. 2010 Jul-Aug;86(4):798-805
pubmed: 20528972
Toxicol In Vitro. 2020 Aug;66:104884
pubmed: 32437906
Aging Cell. 2002 Dec;1(2):117-23
pubmed: 12882341
Dermatol Clin. 2014 Jul;32(3):363-8, ix
pubmed: 24891058
J Dtsch Dermatol Ges. 2021 Jan;19(1):19-29
pubmed: 33491908
J Dermatol Sci. 2017 Nov;88(2):159-166
pubmed: 28711237
J Antimicrob Chemother. 1999 May;43 Suppl B:77-82
pubmed: 10382879
Antimicrob Agents Chemother. 1995 May;39(5):1045-9
pubmed: 7625786
Pigment Cell Res. 2001 Jun;14(3):148-54
pubmed: 11434561
Drug Saf. 2011 Oct 1;34(10):821-37
pubmed: 21879777
Am J Sports Med. 2000 May-Jun;28(3):364-9
pubmed: 10843129
Biosci Rep. 2021 May 28;41(5):
pubmed: 33871027
J Invest Dermatol. 1991 Sep;97(3):405-9
pubmed: 1875041
Clin Dermatol. 2016 Sep-Oct;34(5):571-81
pubmed: 27638435
Drug Saf. 2002;25(5):345-72
pubmed: 12020173
Medicina (Kaunas). 2006;42(8):619-24
pubmed: 16963827
Pigment Cell Res. 1993 Jun;6(3):127-33
pubmed: 8234197
J Photochem Photobiol B. 2000 Oct;58(1):6-12
pubmed: 11195854
Front Oncol. 2022 Mar 14;12:842496
pubmed: 35359389
P T. 2015 Apr;40(4):277-83
pubmed: 25859123
PLoS One. 2012;7(10):e47796
pubmed: 23133524
Wiley Interdiscip Rev Dev Biol. 2018 Mar;7(2):
pubmed: 29244903
Endocrinology. 2018 May 1;159(5):1992-2007
pubmed: 29546369
J Phys Chem B. 2006 Apr 6;110(13):6441-3
pubmed: 16570937

Auteurs

Justyna Kowalska (J)

Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Jagiellońska 4, 41-200 Sosnowiec, Poland.

Klaudia Banach (K)

Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Jagiellońska 4, 41-200 Sosnowiec, Poland.

Zuzanna Rzepka (Z)

Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Jagiellońska 4, 41-200 Sosnowiec, Poland.

Jakub Rok (J)

Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Jagiellońska 4, 41-200 Sosnowiec, Poland.

Marta Karkoszka (M)

Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Jagiellońska 4, 41-200 Sosnowiec, Poland.

Dorota Wrześniok (D)

Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Jagiellońska 4, 41-200 Sosnowiec, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH